Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT04581291 Completed - Covid19 Clinical Trials

The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Participants were assigned randomly into two groups, exercise and control groups. All participants in both groups followed the WHO guidelines of quarantine and used standardized medications given by the physician according to the Turkish Ministry of Health guidelines, including the Hydroxyclorocin Sulphate 200 Mg Film Tablet (Plaquenil 200 Mg Film Tablet). The dose was 2 times/ day, 200Mg/time, for 5 days. Besides, the exercise group performed moderate-intensity aerobic exercises for 40 min/ 3 sessions/week, 40 minute/session.

NCT ID: NCT04581200 Completed - COVID-19 Clinical Trials

Lift Mobile Mindfulness for COVID-19 Distress Symptoms

LIFTCOVID
Start date: January 25, 2021
Phase: N/A
Study type: Interventional

This is a randomized clinical trial (RCT) nested within the NIH PETAL Network's COVID cohort study (BLUE CORAL [Biology and Longitudinal Epidemiology: COVID Observational Study]) of patients hospitalized for COVID-19-related illness. COVID-19 patients enrolled in BLUE CORAL with elevated distress symptoms 1 month post-discharge will be randomized to either the Lift mobile app intervention or a usual care control.

NCT ID: NCT04581135 Completed - COVID-19 Clinical Trials

Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19

Start date: May 1, 2020
Phase:
Study type: Observational [Patient Registry]

Prospective Observational Swiss Cohort Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19.

NCT ID: NCT04581096 Completed - Covid19 Clinical Trials

Mapping COVID-19 Spread in a Tertiary Hospital

MEDyMAP
Start date: October 2, 2020
Phase:
Study type: Observational [Patient Registry]

One of the major problems in suppressing the spreading of an epidemic resides in understanding and monitoring its propagation patterns, and in evaluating how these are modified by enforced policies. The standard solution requires detailed information at the microscopic scales, e.g. how infected people have moved and whom they came in contact with, which is hardly ever available. The researchers propose a novel approach to the study of the propagation of COVID-19, in which a proxy of this information is derived at macroscopic scales. This will be based on two ingredients: the spatiotemporal study in shiny with mathematical models with aggregated or non aggregated data and the reconstruction of functional networks of spreading patterns, and the development of a supporting software.

NCT ID: NCT04581083 Completed - Covid19 Clinical Trials

Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic

Start date: October 8, 2020
Phase:
Study type: Observational

This is a study of validation for diagnostic techniques used on epidemiological control in the COVID-19 pandemic. It will be carried out in accredited public, private and university clinical laboratories of the collaborator institutions of the project based in Tarija, Bolivia. It is designed as a sectional validation study, using samples from specific groups of participants from the municipality of Tarija grouped according to their category with respect to symptoms and viral load of COVID-19. The sample is selected for convenience.

NCT ID: NCT04581044 Completed - Covid19 Clinical Trials

Impact of COVID-19 on Psoriasis Practice

Start date: September 17, 2020
Phase:
Study type: Observational

COVID-19 had a major impact on dermatology practice globally with special emphasis on chronic diseases e.g. psoriasis. The main objective of this work is to investigate the effect of COVID-19 pandemic on psoriasis management. This work is designed as a cross-sectional survey based on a questionnaire directed to Egyptian dermatologists.

NCT ID: NCT04581031 Completed - COVID-19 Clinical Trials

COntinuous Signs Monitoring In Covid-19 Patients

COSMIC-19
Start date: July 11, 2020
Phase: N/A
Study type: Interventional

This is a pilot study to assess whether artificial intelligence (AI) combined with continuous vital signs monitoring from wearable sensors can predict clinically relevant outcomes in patients with suspected or confirmed Covid-19 infection on general medical wards.

NCT ID: NCT04579640 Completed - Covid19 Clinical Trials

Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections

CORONAVIT
Start date: October 27, 2020
Phase: Phase 3
Study type: Interventional

CORONAVIT is an open-label, phase 3, randomised clinical trial testing whether implementation of a test-and-treat approach to correction of sub-optimal vitamin D status results in reduced risk and/or severity of COVID-19 and other acute respiratory infections.

NCT ID: NCT04579627 Completed - COVID Clinical Trials

Facial Hair, PPE and COVID-19

FACIAL HAIR
Start date: May 14, 2020
Phase:
Study type: Observational

An observational cross sectional questionnaire study looking into facial hair of hospital doctors during the COVID-19 pandemic, and how personal protective equipment guidance has affected this.

NCT ID: NCT04579549 Completed - COVID-19 Clinical Trials

Repeat Testing for SARS-CoV-2

Start date: September 29, 2020
Phase: N/A
Study type: Interventional

The purpose of this research study is to determine if high-frequency, rapid turn-around SARS-CoV-2 surveillance testing with this assay is feasible and able to be optimized to enable isolation and follow-up diagnostic testing. This test will be performed at various locations in the Madison, Wisconsin area using a mobile laboratory or standard lab space for processing. Saliva samples can be collected and processed at these locations or participants can self-collect at home and drop their samples off at designated locations for same day processing. Up to 10000 participants will be recruited for this study.